Trupanion [TRUP] vs Hanover Insurance [THG] Detailed Stock Comparison
Trupanion
NASDAQ
Loading...
Hanover Insurance
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Trupanion wins in 0 metrics, Hanover Insurance wins in 16 metrics, with 0 ties. Hanover Insurance appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Trupanion | Hanover Insurance | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 11.12 | N/A |
| Price-to-Book Ratio | 5.90 | 1.88 | Hanover Insurance |
| Debt-to-Equity Ratio | 32.20 | 24.39 | Hanover Insurance |
| PEG Ratio | 813.50 | 12.31 | Hanover Insurance |
| EV/EBITDA | 76.87 | 8.96 | Hanover Insurance |
| Profit Margin (TTM) | 0.81% | 8.67% | Hanover Insurance |
| Operating Margin (TTM) | 0.65% | 12.54% | Hanover Insurance |
| EBITDA Margin (TTM) | 0.65% | 12.54% | Hanover Insurance |
| Return on Equity | 3.33% | 19.23% | Hanover Insurance |
| Return on Assets (TTM) | 0.65% | 3.00% | Hanover Insurance |
| Free Cash Flow (TTM) | $38.57M | $796.20M | Hanover Insurance |
| Dividend Yield | N/A | 1.59% | N/A |
| 1-Year Return | 16.39% | 25.62% | Hanover Insurance |
| Price-to-Sales Ratio (TTM) | 1.54 | 0.94 | Hanover Insurance |
| Enterprise Value | $1.89B | $6.58B | Hanover Insurance |
| EV/Revenue Ratio | 1.39 | 1.03 | Hanover Insurance |
| Gross Profit Margin (TTM) | 14.94% | N/A | N/A |
| Revenue per Share (TTM) | $32 | $178 | Hanover Insurance |
| Earnings per Share (Diluted) | $-0.10 | $15.18 | Hanover Insurance |
| Beta (Stock Volatility) | N/A | 0.46 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Trupanion vs Hanover Insurance Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Trupanion | 2.36% | 5.70% | -0.39% | 12.53% | 9.35% | 5.10% |
| Hanover Insurance | 0.19% | -0.89% | 2.12% | 1.24% | 5.99% | 11.29% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Trupanion | 16.39% | -31.15% | -14.45% | 586.41% | 334.12% | 334.12% |
| Hanover Insurance | 25.62% | 24.18% | 68.11% | 125.64% | 311.57% | 361.87% |
Performance & Financial Health Analysis: Trupanion vs Hanover Insurance
| Metric | TRUP | THG |
|---|---|---|
| Market Information | ||
| Market Cap | $2.10B | $6.04B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 613,960 | 321,370 |
| 90 Day Avg. Volume | 595,197 | 280,787 |
| Last Close | $50.66 | $169.65 |
| 52 Week Range | $31.00 - $57.90 | $131.29 - $178.68 |
| % from 52W High | -12.50% | -5.05% |
| All-Time High | $158.25 (Dec 06, 2021) | $178.68 (Jun 03, 2025) |
| % from All-Time High | -67.99% | -5.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.12% | 0.08% |
| Quarterly Earnings Growth | 0.12% | 2.88% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.09% |
| Operating Margin (TTM) | 0.01% | 0.13% |
| Return on Equity (TTM) | 0.03% | 0.19% |
| Debt to Equity (MRQ) | 32.20 | 24.39 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.27 | $89.59 |
| Cash per Share (MRQ) | $7.44 | $6.82 |
| Operating Cash Flow (TTM) | $69.99M | $857.30M |
| Levered Free Cash Flow (TTM) | $2.00M | $624.16M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.59% |
| Last 12-Month Dividend | N/A | $2.65 |
Valuation & Enterprise Metrics Analysis: Trupanion vs Hanover Insurance
| Metric | TRUP | THG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 11.12 |
| Forward P/E | 813.50 | 12.31 |
| PEG Ratio | 813.50 | 12.31 |
| Price to Sales (TTM) | 1.54 | 0.94 |
| Price to Book (MRQ) | 5.90 | 1.88 |
| Market Capitalization | ||
| Market Capitalization | $2.10B | $6.04B |
| Enterprise Value | $1.89B | $6.58B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.39 | 1.03 |
| Enterprise to EBITDA | 76.87 | 8.96 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.46 |
| Book Value per Share (MRQ) | $8.27 | $89.59 |
Financial Statements Comparison: Trupanion vs Hanover Insurance
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TRUP | THG |
|---|---|---|
| Revenue/Sales | $353.56M | $1.65B |
| Cost of Goods Sold | $298.73M | N/A |
| Gross Profit | $54.83M | N/A |
| Research & Development | $8.59M | N/A |
| Operating Income (EBIT) | $22.16M | N/A |
| EBITDA | $38.03M | N/A |
| Pre-Tax Income | $10.55M | $198.80M |
| Income Tax | $1.13M | $41.90M |
| Net Income (Profit) | $9.41M | $157.10M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TRUP | THG |
|---|---|---|
| Cash & Equivalents | $166.31M | $315.10M |
| Total Current Assets | $628.34M | N/A |
| Total Current Liabilities | $369.34M | N/A |
| Long-Term Debt | $127.53M | $722.50M |
| Total Shareholders Equity | $333.67M | $3.04B |
| Retained Earnings | $-227.37M | $3.31B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TRUP | THG |
|---|---|---|
| Operating Cash Flow | $16.17M | $58.80M |
| Capital Expenditures | $-1.93M | N/A |
| Free Cash Flow | $14.04M | $37.10M |
| Debt Repayment | $-338,000 | N/A |
| Common Stock Repurchase | $-915,000 | $-11.00M |
Short Interest & Institutional Ownership Analysis
| Metric | TRUP | THG |
|---|---|---|
| Shares Short | 7.47M | 579,642 |
| Short Ratio | 12.53 | 2.16 |
| Short % of Float | 0.21% | 0.02% |
| Average Daily Volume (10 Day) | 613,960 | 321,370 |
| Average Daily Volume (90 Day) | 595,197 | 280,787 |
| Shares Outstanding | 42.49M | 35.90M |
| Float Shares | 33.37M | 35.44M |
| % Held by Insiders | 0.06% | 0.01% |
| % Held by Institutions | 0.98% | 0.91% |
Dividend Analysis & Yield Comparison: Trupanion vs Hanover Insurance
| Metric | TRUP | THG |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.65 |
| Last 12-Month Dividend Yield | N/A | 1.59% |
| 3-Year Avg Annual Dividend | N/A | $2.79 |
| 3-Year Avg Dividend Yield | N/A | 0.62% |
| 3-Year Total Dividends | N/A | $8.38 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |